Bone and joint infection after traumatic implantation of Scedosporium prolificans treated with voriconazole and surgery

被引:34
作者
Studahl, M
Backteman, T
Stålhammar, F
Chryssanthou, E
Petrini, B [1 ]
机构
[1] Karolinska Hosp & Inst, Dept Clin Microbiol, SE-17176 Stockholm, Sweden
[2] Sahlgrenska Univ Hosp Ostra, Dept Infect Dis, Gothenburg, Sweden
[3] Sahlgrenska Univ Hosp Ostra, Dept Paediat, Gothenburg, Sweden
[4] Sahlgrenska Univ Hosp Ostra, Dept Radiol, Gothenburg, Sweden
关键词
arthritis; osteomyelitis; Scedosporium prolificans; traumatic implantation; voriconazole;
D O I
10.1080/08035250310004595
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Scedosporium prolificans is an environmental mould that may cause local infection in bone and joints after traumatic implantation, or generalized infection in immunocompromised patients. The fungus is highly drug resistant, both in vitro and in vivo. We present a case of osteomyelitis and arthritis caused by S. prolificans in a 9-y-old boy whose knee had been punctured by a hawthorn spike. Treatment with different drugs was difficult and arthrodesis was necessary. Concomitantly, voriconazole was given, and after three months bone biopsies were sterile despite a high in vitro MIC-value of the fungus against voriconazole. Reversible skin depigmentation and fingernail oncholysis appeared toward the end of 17 months of voriconazole treatment. Twelve months after discontinuation of treatment, no signs of relapse were detected. Conclusion: Voriconazole may be a valuable adjunct to surgical treatment of bone and joint infection by Scedosporium prolificans.
引用
收藏
页码:980 / 982
页数:3
相关论文
共 14 条
[1]   Deep infections caused by Scedosporium prolificans - A report on 16 cases in Spain and a review of the literature [J].
Berenguer, J ;
RodriguezTudela, JL ;
Richard, C ;
Alvarez, M ;
Sanz, MA ;
Gaztelurrutia, L ;
Ayats, J ;
MartinezSuarez, JV .
MEDICINE, 1997, 76 (04) :256-265
[2]   Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor [J].
Bouza, E ;
Munoz, P ;
Vega, L ;
RodriguezCreixems, M ;
Berenguer, J ;
Escudero, A .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (01) :192-193
[3]   Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum [J].
Cuenca-Estrella, M ;
Ruiz-Díez, B ;
Martínez-Suárez, JV ;
Monzón, A ;
Rodríguez-Tudela, JL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (01) :149-151
[4]  
de Hoog G.S., 2000, ATLAS CLIN FUNGI, VSecond
[5]   Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole [J].
Denning, DW ;
Griffiths, CEM .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2001, 26 (08) :648-653
[6]   Antifungal Triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum [J].
Gil-Lamaignere, C ;
Roilides, E ;
Mosquera, J ;
Maloukou, A ;
Walsh, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) :2234-2237
[7]   Disseminated infection by Scedosporium prolificans:: an emerging fatality among haematology patients.: Case report and review [J].
Maertens, J ;
Lagrou, K ;
Deweerdt, H ;
Surmont, I ;
Verhoef, GEG ;
Verhaegen, J ;
Boogaerts, MA .
ANNALS OF HEMATOLOGY, 2000, 79 (06) :340-344
[8]   CHRONIC, RECURRENT OSTEOMYELITIS CAUSED BY SCEDOSPORIUM-INFLATUM [J].
MALEKZADEH, M ;
OVERTURF, GD ;
AUERBACH, SB ;
WONG, L ;
HIRSCH, M .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (05) :357-359
[9]   In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans [J].
Meletiadis, J ;
Mouton, JW ;
Rodriguez-Tudela, JL ;
Meis, JFGM ;
Verweij, PE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :470-472
[10]   In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates [J].
Meletiadis, J ;
Meis, JFGM ;
Mouton, JW ;
Rodriquez-Tudela, JL ;
Donnelly, JP ;
Verweij, PE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :62-68